Nutrición Hospitalaria 00215 / http://dx.doi.org/10.20960/nh.215

Trabajo Original

Effects of a high-fat meal on postprandial incretin responses, appetite scores and ad libitum energy intake in women with obesity

Fernanda Rodrigues O. Penaforte, Camila C. Japur, Rosa W. Diez-garcia, Paula G. Chiarello

VOLUMEN 34, NÚM. 2, marzo-abril (2017), PAG. 376-382

Logo Descargas Número de descargas: 6613 Logo Visitas Número de visitas: 7944 Citas Citas: 0

Compártelo:

Background: Considering the possible role of triglycerides (TG), glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) in the regulation of appetite, this study aimed to compare high fat meal-induced response of GIP and GLP-1, appetite scores and ad libitum energy intake in women with obesity, according to postprandial increment in triglyceridemia (∆TG). Methods: Thirty-three no-diabetic women (BMI = 35.0 ± 3.2 kg.m-2) were divided into two groups: Group with ∆TG ≤ median were called “Low TG change -LTG” and ∆TG > median, “High TG change - HTG”. Plasma concentrations of GIP, GLP-1 and appetite sensations were measured prior to, and every 30 min for 180 min after ingestion of a high-fat breakfast. An ad libitum lunch was served 3 h after the test meal.Results: The AUC incrementalGIP were significant lower in HTG vs. LTG group (p = 0.03). The same was observed for GIP levels at 150 min (p = 0.03) and at 180 min (p < 0.01). Satiety was lower in HTG at 120 min (p = 0.03) and 150 min (p < 0.01). The AUC totalGLP1 were similar between groups and there were no between-group differences for the GLP-1 at each time point. Ad libitum food intake were also similar between groups.Conclusions: The HTG group exhibited differences in satiety scores and lower postprandial secretion of GIP, however with no impact on ad libitum food intake in short term.

Palabras Clave: Incretins. Glucagonlike peptide 1. Glucose-dependent insulinotropic polypeptide. Hunger. Appetite. Food intake

Descargar PDF (ENGLISH)

Bibliografía

Harrold JA, Doyey TM, Blundell JE, Halford JCG. CNS regulation of appetite. Neuropharmacology. 2012;63(1):3-17.

Flint A, Raben A, Ersboll AK, Holst JJ, Astrup A. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. International Journal of Obesity. 2001;25(6):781-92.

Verdich C, Flint A, Gutzwiller JP, Naslund E, Beglinger C, Hellstrom PM, et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. Journal of Clinical Endocrinology & Metabolism. 2001;86(9):4382-9.

Schirra J, Goke B. The physiological role of GLP-1 in human: Incretin, ileal brake or more? Regulatory Peptides. 2005;128(2):109-15.

Verdich C, Toubro S, Buemann B, Madsen JL, Holst JJ, Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction. International Journal of Obesity. 2001;25(8):1206-14.

Lugari R, Dei Cas A, Ugolotti D, Barilli AL, Camellini C, Ganzerla GC, et al. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. Hormone and Metabolic Research. 2004;36(2):111-5.

Carr RD, Larsen MO, Jelic K, Lindgren O, Vikman J, Holst JJ, et al. Secretion and Dipeptidyl Peptidase-4-Mediated Metabolism of Incretin Hormones after a Mixed Meal or Glucose Ingestion in Obese Compared to Lean, Nondiabetic Men. Journal of Clinical Endocrinology & Metabolism. 2010;95(2):872-8.

Naslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, et al. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. International Journal of Obesity. 1999;23(3):304-11.

Asmar M, Bache M, Knop FK, Madsbad S, Holst JJ. Do the Actions of Glucagon-Like Peptide-1 on Gastric Emptying, Appetite, and Food Intake Involve Release of Amylin in Humans? Journal of Clinical Endocrinology & Metabolism. 2010;95(5):2367-75.

Edholm T, Degerblad M, Gryback P, Hilsted L, Holst JJ, Jacobsson H, et al. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis. Neurogastroenterology and Motility. 2010;22(11):1191-+.

Raben A, Andersen HB, Christensen NJ, Madsen J, Holst JJ, Astrup A. Evidence for an abnormal postprandial response to a high-fat meal in women predisposed to obesity. American Journal of Physiology-Endocrinology and Metabolism. 1994;267(4):E549-E59.

Raben A, Tagliabue A, Christensen NJ, Madsen J, Holst JJ, Astrup A. Resistant starch - the effect on postprandial glycemia, hormonal response, and satiety. American Journal of Clinical Nutrition. 1994;60(4):544-51.

Raben A, Andersen K, Karberg MA, Holst JJ, Astrup A. Acetylation of or beta-cyclodextrin addition to potato starch: Beneficial effect on glucose metabolism and appetite sensations. American Journal of Clinical Nutrition. 1997;66(2):304-14.

Daousi C, Wilding JPH, Aditya S, Durham BH, Cleator J, Pinkney JH, et al. Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes Clinical Endocrinology; 2009. p. 195-201.

Stock S, Leichner P, Wong ACK, Ghatei MA, Kieffer TJ, Bloom SR, et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. Journal of Clinical Endocrinology & Metabolism. 2005;90(4):2161-8.

Chang GQ, Karatayev O, Davydova Z, Leibowitz SF. Circulating triglycerides impact on orexigenic peptides and neuronal activity in hypothalamus. Endocrinology. 2004;145(8):3904-12.

Chang GQ, Karatayev O, Ahsan R, Gaysinskaya V, Marwil Z, Leibowitz SF. Dietary fat stimulates endogenous enkephalin and dynorphin in the paraventricular nucleus: role of circulating triglycerides. American Journal of Physiology-Endocrinology and Metabolism. 2007;292(2):E561-E70.

Leibowitz SF, Dourmashkin JT, Chang GQ, Hill JO, Gayles EC, Fried SK, et al. Acute high-fat diet paradigms link galanin to triglycerides and their transport and metabolism in muscle. Brain Research. 2004;1008(2):168-78.

Gaysinskaya VA, Karatayev O, Chang GQ, Leibowitz SF. Increased caloric intake after a high-fat preload: Relation to circulating triglycerides and orexigenic peptides. Physiology & Behavior. 2007;91(1):142-53.

Giacco R, Clemente G, Busiello L, Lasorella G, Rivieccio AM, Rivellese AA, et al. Insulin sensitivity is increased and fat oxidation after a high-fat meal is reduced in normal-weight healthy men with strong familial predisposition to overweight. International Journal of Obesity. 2003;27(7):790-6.

Casas-Agustench P, Lopez-Uriarte P, Bullo M, Ros E, Gomez-Flores A, Salas-Salvado J. Acute effects of three high-fat meals with different fat saturations on energy expenditure, substrate oxidation and satiety. Clinical Nutrition. 2009;28(1):39-45.

Phillips LK, Prins JB. Update on incretin hormones. Annals of the New York Academy of Sciences; 2012. p. 1-20.

Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132(6):2131-57.

Adam TCM, Westerterp-Plantenga MS. Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects. British Journal of Nutrition. 2005;93(6):845-51.

Vilsboll T, Krarup T, Sonne J, Madsbad S, Volund A, Juul AG, et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Journal of Clinical Endocrinology & Metabolism. 2003;88(6):2706-13.

Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scares in assessment of appetite sensations in single test meal studies. International Journal of Obesity. 2000;24(1):38-48.

Karatayev O, Gaysinskaya V, Chang GQ, Leibowitz SF. Circulating triglycerides after a high-fat meal: predictor of increased caloric intake, orexigenic peptide expression, and dietary obesity. Brain Res. 2009;1298:111-22.

Chang G-Q, Gaysinskaya V, Karatayev O, Leibowitz SF. Maternal High-Fat Diet and Fetal Programming: Increased Proliferation of Hypothalamic Peptide-Producing Neurons That Increase Risk for Overeating and Obesity. Journal of Neuroscience. 2008;28(46):12107-19.

Friedman MI, Harris RB, Ji H, Ramirez I, Tordoff MG. Fatty acid oxidation affects food intake by altering hepatic energy status. American Journal of Physiology-Regulatory Integrative and Comparative Physiology. 1999;276(4):R1046-R53.

Wilding JPH. Neuropeptides and appetite control. Diabetic Medicine. 2002;19(8):619-27.

Zhu Y, Hsu W, Hollis J. Increasing the number of masticatory cycles is associated with reduced appetite and altered postprandial plasma concentrations of gut hormones, insulin and glucose British Journal of Nutrition; 2013. p. 384-90.

Yip RGC, Wolfe MM. GIP biology and fat metabolism. Life Sciences. 2000;66(2):91-103.

Karras S, Goulis DG, Mintziori G, Katsiki N, Tzotzas T. The Effects of Incretins on Energy Homeostasis: Physiology and Implications for the Treatment of Type 2 Diabetes Mellitus and Obesity. Current Vascular Pharmacology. 2012;10(6):781-91.

Long SJ, Sutton JA, Amaee WB, Giouvanoudi A, Spyrou NM, Rogers PJ, et al. No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man. British Journal of Nutrition. 1999;81(4):273-9.

Hansen L, Deacon CF, Orskov C, Holst JJ. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology. 1999;140(11):5356-63.

Burcelin R. The incretins: a link between nutrients and well-being. British Journal of Nutrition. 2005;93:S147-S56.

Mul J, Begg D, Barrera J, Li B, Matter E, D’Alessio D, et al. High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats Am J Physiol Regul Integr Comp Physiol; 2013.

Anini Y, Brubaker PL. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes. 2003;52(2):252-9.

Williams DL, Hyvarinen N, Lilly N, Kay K, Dossat A, Parise E, et al. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation. Physiology & Behavior. 2011;103(5):557-64.

Poitout V. Lipotoxicity impairs incretin signalling. Diabetologia. 2013;56(2):231-3.

Kang ZF, Deng Y, Zhou Y, Fan RR, Chan JCN, Laybutt DR, et al. Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes. Diabetologia. 2013;56(2):423-33.
DOI: 10.1007/s00125-012-2776-x